STORY OF OUR FIRM

Sunday, July 20, 2008

Clinical Trials for Mesothelioma Patients: Immunotoxin Therapy

Read about a current clinical trial being conducted to study the effects of Immunotoxin Therapy for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the study is currently being conducted only in Zurich, Switzerland.

Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery

Rationale: Immunotoxins can find tumor cells and kill them without harming normal cells. Drugs used in chemotherapy, such as pemetrexed and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) together with immunotoxin therapy may kill more malignant mesothelioma cells.

Purpose: This phase I trial is studying the side effects and best dose of immunotoxin therapy when given together with pemetrexed and cisplatin in treating patients with malignant pleural mesothelioma that cannot be removed by surgery.

Requisite Conditions: Malignant Mesothelioma

Intervention: Drugs: SS1(dsFv)-PE38 immunotoxin; cisplatin; pemetrexed disodium Procedures: chemotherapy; immunoenzyme technique; immunohistochemistry staining method; immunotoxin therapy; pharmacological study; quality-of-life assessment

Study Design and Type: Phase I Interventional; Treatment, Non-Randomized, Open Label, Active Control

Official Title: A Phase I, Single Center, Dose-Escalation Study of CAT-5001 Administered Concurrently With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Epithelial Pleural Mesothelioma

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma & Asbestosis Mortalities Across the US: 1979-2001 (c/o EWG)

“We have seen first-hand how asbestos has wreaked havoc on Americans working in naval shipyards, automobile plants, and the construction industry. Most often this is through their employers’ conscious choice for profits over a worker's health.”

-- Joseph Patrick Williams, a trial attorney in the Asbestos Litigation department of Weitz & Luxenberg

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
	Mesothelioma Home Page
	Mesothelioma: An Overview
	The Clock Is Ticking
	Our Toughest Cases
	Diagnosis
	Symptoms, Stages, Treatment
	Latest News
	New York Numbers
	Asbestos
IN THIS SECTION Antineoplaston therapy for mesothelioma patients Antineoplaston trial for mesothelioma patients Antineoplaston clinical trial for mesothelioma Antineoplaston therapy for mesothelioma patients Antineoplaston test for mesothelioma patients AZD2171 therapy for mesothelioma patients AZD2171 trial for mesothelioma patients AZD2171 trial for mesothelioma disease Mesothelioma patient study of AZD2171 effects AZD2171 therapy for mesothelioma patients Contact info for mesothelioma AZD2171 facilities Current Bortezomib therapy for mesothelioma Bortezomib trial description for mesothelioma Outcomes of Bortezomib against mesothelioma cancer Criteria of Bortezomib study on mesothelioma test Effects of Bortezomib trial on mesothelioma cancer Bortezomib therapy for mesothelioma patients Current Dasatinib therapy for mesothelioma NSC 732517 trial description for mesothelioma NSC 732517 trial for mesothelioma patients Eligibility for mesothelioma trial of NSC 732517 Mesothelioma patient profile for NSC 732517 trial Mesothelioma therapy criteria to test NSC 732517 Information on NSC 732517 trial for mesothelioma Bortezomib therapy for mesothelioma patients Bortezomib and Cisplatin in mesothelioma trial Cisplatin therapy for mesothelioma patients Bortezomib and Cisplatin in mesothelioma trial Mesothelioma therapy criteria to test NSC 732517 Information on NSC 732517 trial for mesothelioma Current Imatinib therapy for mesothelioma patients Imatinib Mesylate trial for mesothelioma patients Outcomes of Imatinib against mesothelioma cancer Recruitment data to test Imatinib on mesothelioma Inclusion standard in Imatinib mesothelioma trial Exclusion standard in Imatinib mesothelioma trial Contact info for Imatinib mesothelioma study Current Immunotoxin therapy: mesothelioma patients Immunotoxin therapy for mesothelioma patients Objectives of Immunotoxin trial on mesothelioma Study outline for Immunotoxin mesothelioma trial Disease traits in Immunotoxin mesothelioma trial Patient traits: Immunotoxin mesothelioma trial Contact info for Immunotoxin mesothelioma program Early mesothelioma symptoms from Canada asbestos Canada study criteria of early mesothelioma traits Contact info for mesothelioma program in Canada Cisplatin and Pemetrexed therapy for mesothelioma Description of Pemetrexed mesothelioma study Inclusion standard in Pemetrexed mesothelioma test Exclusion standard in Pemetrexed mesothelioma test Contact info for Pemetrexed mesothelioma study NGR for mesothelioma NGR drug trials against mesothelioma NGR for mesothelioma study Exclusion criteria for mesothelioma NGR study Contact for Antineoplaston test on mesothelioma Pazopanib for mesothelioma patients Pazopanib for mesothelioma study Pazopanib inclusion criteria at mesothelioma trial Patient criteria for mesothelioma Pazopanib study Pazopanib for mesothelioma therapy Pemetrexed drug for mesothelioma patients Pemetrexed drug study for mesothelioma patients Pemetrexed and cisplatin for mesothelioma patients Pemetrexed study outline for mesothelioma patients Pemetrexed disodium drug trial for mesothelioma Pemetrexed trials for mesothelioma patients Pemetrexed trials for mesothelioma patients Contact info: Pemetrexed trial for mesothelioma Vitamin B12 test on mesothelioma patients Vitamin B12 study on mesothelioma patients Outcome of Vitamin B12 on mesothelioma patients Vitamin B12 outline for mesothelioma study Patient criteria for B12 study on mesothelioma Criteria of Vitamin B12 therapy on mesothelioma Contact info of mesothelioma clinical trial of B12 Novartis LBH589 for mesothelioma Novartis LBH589 for mesothelioma study LBH589 trial for mesothelioma Clinical LBH589 for mesothelioma Clinical trial for esophageal cancer, mesothelioma Clinical trial of hTNF for mesothelioma Valproate for Mesothelioma Vandetanib tested for mesothelioma Vorinostat tested for mesothelioma RETURN BACK TO Mesothelioma Symptoms, Stages, Treatment of Mesothelioma Treatment

see also: AZD2171 trial for mesothelioma patients Clinical trial to treat mesothelioma patients with AZD2171 therapy Program objectives for mesothelioma patients in AZD2171 clinical trial Contact info for Pemetrexed mesothelioma study Contact information for mesothelioma clinical trial of Pemetrexed Contact the facilities involved in Pemetrexed mesothelioma cancer test Clinical trials on asbestos illness: mesothelioma Info about clinical trials on mesothelioma, an asbestos illness Information on clinical trials of the asbestos illness, mesothelioma

Name	Phone	Email

Do you have a legal question? Ask us! strictly confidential

Your Question